Thin basement membrane nephropathy (benign familial haematuria)
TBMN · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Usually benign cause of persistent/recurrent glomerular haematuria due to diffusely thinned GBM, often from heterozygous COL4A3/COL4A4 variants. Most retain normal function, but a minority progress, so proteinuria and BP must be monitored.
Red flags
- New or increasing proteinuria
- Declining eGFR
- Hearing loss or ocular changes (suggests Alport)
- Family history of kidney failure
- Visible haematuria with clots (consider urological cause)
Assessment
Differential diagnosis
- Alport syndrome (carrier/autosomal)
- IgA nephropathy
- Other glomerulonephritis
- Urological bleeding source
- Hypercalciuria/hyperuricosuria
- Exercise-induced haematuria
Investigations
- Urinalysis/microscopy (dysmorphic RBCs, no/low proteinuria)
- Urine ACR/PCR
- Renal function
- Family history and urinalysis of relatives
- Audiometry/ophthalmology to exclude Alport features
- Genetic testing or biopsy with EM (thin GBM) only if diagnosis uncertain or proteinuria present
Management
- Confirm persistent glomerular haematuria with dysmorphic red cells and minimal proteinuria
- Exclude urological causes in older patients or where risk factors exist (imaging, cystoscopy as indicated)
- Take a family history and consider screening relatives for haematuria
- Distinguish from Alport by assessing hearing, eyes, proteinuria and family history of kidney failure
- Reserve biopsy/genetics for atypical features: significant proteinuria, declining eGFR, or suspected Alport
- Reassure if isolated haematuria with normal function and no proteinuria (benign course)
- Treat hypertension and any proteinuria with an ACE inhibitor/ARB
- Avoid unnecessary nephrotoxins
- Arrange periodic monitoring of BP, eGFR and ACR
- Escalate to full Alport work-up if proteinuria develops or function declines
- Provide genetic counselling where a pathogenic COL4 variant is identified
- Document long-term follow-up plan
Drugs & doses
Ramipril 2.5-10 mg PO daily (only if proteinuria/hypertension)
Losartan 50-100 mg PO daily (alternative)
Disposition
Primary care or nephrology clinic monitoring. Reassurance for classic benign cases. Nephrology/genetics referral if proteinuria, declining function or Alport features.
Complications & pitfalls
- Minority progress to CKD (overlap with autosomal Alport)
- Unnecessary invasive investigation if misattributed
- Missed urological malignancy if haematuria not fully assessed in older patients
Exam pearls
- Isolated haematuria with normal function and no proteinuria is usually benign
- Proteinuria or declining function should prompt Alport work-up
- Family urinalysis is a cheap, informative test
- Genetically it overlaps with autosomal-dominant Alport (COL4A3/4)
- Still exclude urological causes of haematuria in older patients
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.